Arteriovenous fistula use in the United States and dialysis facility–level comorbidity burden
American Journal of Kidney Diseases Dec 05, 2019
Dahlerus C, et al. - In this retrospective cohort study, researchers characterized variation in facility-level use of arteriovenous fistulas (AVFs) across the facility-level burden of patient comorbid conditions. Overall, the use of AVF was 65.8% among 5,813 facilities in 315,919 prevalent patients with hemodialysis. According to findings, small variations were found in facility rates of AVF use except in the extremes of high or low levels of comorbidity burden after adjustment for patient characteristics. Findings reveal that dialysis facilities with a relatively high patient comorbidity burden can achieve comparable rates of a fistula to facilities with healthier individuals. While high comorbidity burden does not explain low AVF use facilities, further research is required to understand differences in AVF use rates among facilities with comparable comorbidity burdens.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries